The neuropeptide pituitary adenylate cyclase–activating polypeptide and islet function

K Filipsson, M Kvist-Reimer, B Ahrén - Diabetes, 2001 - Am Diabetes Assoc
K Filipsson, M Kvist-Reimer, B Ahrén
Diabetes, 2001Am Diabetes Assoc
The neuropeptide pituitary adenylate cyclase–activating polypeptide (PACAP) is
ubiquitously distributed in both the central and peripheral nervous systems and exerts a
variety of effects. PACAP is a neuropeptide in pancreatic islets, where it has been suggested
as a parasympathetic and sensory neurotransmitter. PACAP stimulates insulin secretion in a
glucose-dependent manner, by an effect executed mainly through augmenting the formation
of cAMP and stimulating the uptake of calcium. Accumulating evidence in animal studies …
The neuropeptide pituitary adenylate cyclase–activating polypeptide (PACAP) is ubiquitously distributed in both the central and peripheral nervous systems and exerts a variety of effects. PACAP is a neuropeptide in pancreatic islets, where it has been suggested as a parasympathetic and sensory neurotransmitter. PACAP stimulates insulin secretion in a glucose-dependent manner, by an effect executed mainly through augmenting the formation of cAMP and stimulating the uptake of calcium. Accumulating evidence in animal studies points to a physiological importance of PACAP in the regulation of the insulin response to feeding. This review summarizes the current knowledge of islet actions and mechanisms and the function of PACAP.
Am Diabetes Assoc